Cerenome, Inc. SEC filings CNSY

Cerenome, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 14, 2011. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (other events). The company's fiscal year ends on December 31.

Cerenome, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 2, 2026 Oct 2, 2026
D Filing Sep 18, 2026 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 10, 2026 Sep 4, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
8-K Current report
Bylaw or fiscal year change
Aug 4, 2026 Aug 3, 2026
S-8 Employee stock plan registration Jun 18, 2026 —
EFFECT Filing Jun 5, 2026 —
8-K Current report
Material agreement
Jun 5, 2026 Jun 1, 2026
CORRESP Letter to the SEC Jun 5, 2026 —
S-3/A Filing Jun 5, 2026 —
UPLOAD Letter from the SEC Jun 4, 2026 —
S-3 Shelf registration Jun 2, 2026 —
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
8-K Current report
Other events
Apr 21, 2026 Apr 20, 2026
8-K Current report
Officer or director change
Apr 9, 2026 Apr 8, 2026
8-K Current report
Other events
Apr 8, 2026 Apr 8, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 2, 2026 Apr 1, 2026
DEFA14A Additional proxy material Mar 31, 2026 —
ARS Annual report to shareholders Mar 31, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 31, 2026 May 14, 2026
8-K Current report
Officer or director change
Mar 26, 2026 Mar 20, 2026
8-K Current report
Other events
Mar 12, 2026 Mar 11, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
RW Filing Mar 6, 2026 —
8-K Current report
Officer or director change
Feb 13, 2026 Feb 9, 2026
8-K Current report
Other events
Jan 22, 2026 Jan 22, 2026
8-K Current report
Material agreement, Other events
Jan 16, 2026 Jan 13, 2026
424B4 Prospectus Jan 14, 2026 —
EFFECT Filing Jan 13, 2026 —
S-1MEF Filing Jan 13, 2026 —
CORRESP Letter to the SEC Jan 9, 2026 —
CORRESP Letter to the SEC Jan 9, 2026 —
S-1 Registration statement Jan 9, 2026 —
DRS Filing Nov 25, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Material agreement, New debt
Oct 21, 2025 Oct 16, 2025
8-K Current report
Other events
Aug 26, 2025 Aug 26, 2025
S-8 Employee stock plan registration Aug 22, 2025 —
424B3 Prospectus Aug 15, 2025 —
EFFECT Filing Aug 14, 2025 —
8-K Current report
Other events
Aug 14, 2025 Aug 14, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Other events
Aug 13, 2025 Aug 13, 2025
CORRESP Letter to the SEC Aug 12, 2025 —
8-K Current report
Shareholder vote results
Aug 12, 2025 Aug 7, 2025
S-1 Registration statement Aug 12, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
DRS Filing Aug 4, 2025 —
DEFA14A Additional proxy material Aug 1, 2025 —
RW Filing Jul 25, 2025 —
ARS Annual report to shareholders Jul 21, 2025 Dec 31, 2024
DEF 14A Proxy statement Jul 21, 2025 Aug 7, 2025
8-K Current report
Auditor change
Jul 18, 2025 Jul 16, 2025
PRE 14A Preliminary proxy statement Jul 11, 2025 Aug 7, 2025
EFFECT Filing Jun 23, 2025 —
RW Filing Jun 23, 2025 —
424B3 Prospectus Jun 23, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jun 20, 2025 Jun 17, 2025
S-1/A Amended registration statement Jun 20, 2025 —
S-1 Registration statement Jun 18, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
8-K Current report
Material agreement, Change to shareholder rights
Jun 17, 2025 Jun 17, 2025
UPLOAD Letter from the SEC Jun 13, 2025 —
DRS Filing Jun 9, 2025 —
8-K Current report
Listing notice
Jun 6, 2025 Jun 3, 2025
8-K Current report
Results of operations
May 30, 2025 May 30, 2025
10-Q Quarterly report May 30, 2025 Mar 31, 2025
8-K Current report
Listing notice, Regulation FD disclosure
May 23, 2025 May 21, 2025
8-K Current report
Listing notice
May 19, 2025 May 16, 2025
NT 10-Q Filing May 15, 2025 Mar 31, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
May 2, 2025 May 2, 2025
DEFA14A Additional proxy material May 1, 2025 —
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
S-3/A Filing Apr 23, 2025 —
424B3 Prospectus Apr 18, 2025 —
8-K Current report
Officer or director change
Apr 18, 2025 Apr 18, 2025
POS AM Filing Apr 11, 2025 —
UPLOAD Letter from the SEC Apr 11, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 2, 2025
S-3 Shelf registration Apr 4, 2025 —
CORRESP Letter to the SEC Apr 1, 2025 —
PRER14A Filing Apr 1, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
RW Filing Mar 31, 2025 —
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
UPLOAD Letter from the SEC Mar 24, 2025 —
PRE 14A Preliminary proxy statement Mar 14, 2025 Mar 14, 2025
424B3 Prospectus Mar 10, 2025 —
8-K Current report
Other events
Mar 10, 2025 Mar 7, 2025
424B3 Prospectus Mar 4, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Mar 4, 2025 Mar 4, 2025
424B3 Prospectus Feb 18, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Feb 18, 2025 Feb 13, 2025
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
424B3 Prospectus Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
424B3 Prospectus Nov 1, 2024 —
8-K Current report
Other events
Nov 1, 2024 Oct 30, 2024
S-3 Shelf registration Oct 4, 2024 —
424B3 Prospectus Sep 6, 2024 —
8-K Current report
Listing notice
Sep 6, 2024 Sep 5, 2024
S-8 Employee stock plan registration Aug 23, 2024 —
424B3 Prospectus Aug 15, 2024 —
8-K Current report
Shareholder vote results
Aug 15, 2024 Aug 15, 2024
424B3 Prospectus Aug 14, 2024 —
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
DEFA14A Additional proxy material Jul 12, 2024 —
ARS Annual report to shareholders Jul 10, 2024 Dec 31, 2023
DEF 14A Proxy statement Jul 10, 2024 Aug 15, 2024
EFFECT Filing Jun 24, 2024 —
424B3 Prospectus Jun 24, 2024 —
S-1/A Amended registration statement Jun 24, 2024 —
CORRESP Letter to the SEC Jun 20, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
S-1 Registration statement Jun 7, 2024 —
8-K Current report
Officer or director change
Jun 7, 2024 Jun 5, 2024
8-K Current report
Material agreement, Agreement ended, New debt
Jun 4, 2024 May 31, 2024
8-K Current report
Other events
May 20, 2024 May 16, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Material agreement, Unregistered share sale
May 9, 2024 May 5, 2024
8-K Current report
Listing notice
Mar 14, 2024 Mar 8, 2024
8-K Current report
Regulation FD disclosure
Mar 13, 2024 Mar 12, 2024
S-1/A Amended registration statement Mar 8, 2024 —
8-K Current report
Results of operations
Mar 5, 2024 Mar 5, 2024
10-K Annual report Mar 5, 2024 Dec 31, 2023
424B3 Prospectus Nov 22, 2023 —
S-1 Registration statement Nov 22, 2023 —
EFFECT Filing Nov 20, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Nov 20, 2023 Nov 20, 2023
CORRESP Letter to the SEC Nov 17, 2023 —
UPLOAD Letter from the SEC Nov 17, 2023 —
S-1 Registration statement Nov 14, 2023 —
8-K Current report
Other events
Oct 31, 2023 Oct 31, 2023
8-K Current report
Results of operations
Oct 31, 2023 Oct 31, 2023
10-Q Quarterly report Oct 31, 2023 Sep 30, 2023
424B3 Prospectus Aug 21, 2023 —
EFFECT Filing Aug 18, 2023 —
CORRESP Letter to the SEC Aug 16, 2023 —
UPLOAD Letter from the SEC Aug 16, 2023 —
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
S-1 Registration statement Aug 9, 2023 —
8-K Current report
Other events
May 16, 2023 May 15, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
Apr 28, 2023 Apr 27, 2023
8-K Current report
Shareholder vote results
Apr 21, 2023 Apr 20, 2023
8-K Current report
Results of operations
Apr 20, 2023 Apr 20, 2023
10-Q Quarterly report Apr 20, 2023 Mar 31, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
DEF 14A Proxy statement Mar 7, 2023 Apr 20, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Mar 3, 2023 Mar 3, 2023
PRE 14A Preliminary proxy statement Feb 24, 2023 Apr 20, 2023
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Other events
Dec 15, 2022 Dec 9, 2022
8-K Current report
Listing notice
Nov 28, 2022 Nov 22, 2022
8-K Current report
Results of operations
Oct 20, 2022 Oct 20, 2022
10-Q Quarterly report Oct 20, 2022 Sep 30, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Sep 22, 2022 Sep 19, 2022
8-K Current report
Material agreement
Sep 9, 2022 Sep 9, 2022
424B5 Prospectus supplement Sep 9, 2022 —
424B3 Prospectus Aug 18, 2022 —
EFFECT Filing Aug 17, 2022 —
8-K Current report
Other events
Aug 17, 2022 Aug 13, 2022
CORRESP Letter to the SEC Aug 15, 2022 —
UPLOAD Letter from the SEC Aug 15, 2022 —
S-1 Registration statement Aug 9, 2022 —
8-K Current report
Material agreement, Agreement ended, Unregistered share sale
Aug 8, 2022 Aug 2, 2022
8-K Current report
Results of operations
Jul 21, 2022 Jul 21, 2022
10-Q Quarterly report Jul 21, 2022 Jun 30, 2022
8-K Current report
Listing notice
May 27, 2022 May 24, 2022
8-K Current report
Shareholder vote results
May 20, 2022 May 16, 2022
8-K Current report
Results of operations
Apr 21, 2022 Apr 21, 2022
10-Q Quarterly report Apr 21, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
DEF 14A Proxy statement Apr 7, 2022 May 16, 2022
8-K Current report
Material agreement, Regulation FD disclosure
Apr 5, 2022 Mar 31, 2022
PRE 14A Preliminary proxy statement Mar 28, 2022 Mar 28, 2022
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Material agreement
Jan 14, 2022 Jan 14, 2022
424B5 Prospectus supplement Jan 14, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure
Jan 6, 2022 Dec 31, 2021
8-K Current report
Regulation FD disclosure, Other events
Nov 18, 2021 Nov 18, 2021
8-K Current report
Results of operations
Oct 21, 2021 Oct 21, 2021
10-Q Quarterly report Oct 21, 2021 Sep 30, 2021
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 21, 2021 Sep 15, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 13, 2021 Sep 7, 2021
EFFECT Filing Sep 10, 2021 —
424B3 Prospectus Sep 10, 2021 —
CORRESP Letter to the SEC Sep 8, 2021 —
UPLOAD Letter from the SEC Sep 8, 2021 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CNSY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1095981
Former names
PLUS THERAPEUTICS, INC. (until Jul 1, 2026); CYTORI THERAPEUTICS, INC. (until Aug 2, 2019); MACROPORE INC (until Jul 5, 2005)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.